ホーム › バーキットリンパ腫 › フロリダ州

フロリダ州におけるバーキットリンパ腫の臨床試験

フロリダ州内の拠点で、バーキットリンパ腫に関する15件の研究が参加者を募集しています。

フロリダ州内の都市

公式研究テキスト（英語）

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
他9件

被験者募集中第2相

366 Days – 46 Years · 全性別 · 2026/10/02更新 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
Orlando Health Cancer Institute, Orlando

被験者募集中第3相

18歳〜39歳 · 全性別 · 2026/10/02更新 · NCT03150693

Blinatumomab Consolidation in Real World

Mayo Clinic Cancer Center, Jacksonville

被験者募集中観察研究健康なボランティア歓迎

18歳以上 · 全性別 · 2026/10/01更新 · NCT07117136

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Jupiter Medical Center, Jupiter

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/29更新 · NCT03739814

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Moffitt Cancer Center, Tampa

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06144606

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
Nemours Children's Clinic-Jacksonville, Jacksonville
他8件

被験者募集中第2相

365 Days · 全性別 · 2026/09/25更新 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

SSAK Partners, Coral Springs
Mayo Clinic - Jacksonville, Jacksonville

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/21更新 · NCT07648264

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg

被験者募集中第1/2相

6 Months – 25 Years · 全性別 · 2026/09/17更新 · NCT06395103

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

H. Lee Moffitt Cancer Center, Tampa

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/08更新 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
他9件

被験者募集中第2相

1歳〜30歳 · 全性別 · 2026/09/01更新 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Broward Health Medical Center, Fort Lauderdale
Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
他12件

被験者募集中第3相

365 Days – 25 Years · 全性別 · 2026/08/25更新 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, Tampa

被験者募集中第1/2相

12歳以上 · 全性別 · 2026/08/19更新 · NCT06137118

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Mayo Clinic, Clinical Trials Referral Office, Jacksonville

被験者募集中第1/2相

13歳〜90歳 · 全性別 · 2026/08/06更新 · NCT06533579

Study of SGR-1505 in Mature B-Cell Neoplasms

Napa Research, Pompano Beach

被験者募集中第1相

18歳以上 · 全性別 · 2026/02/13更新 · NCT05544019

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

University of Florida, Gainesville
Nicklaus Children's Hospital, Miami
Johns Hopkins All Children's Hospital, St. Petersburg

被験者募集中第2相

1歳〜25歳 · 全性別 · 2025/05/04更新 · NCT03509961

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。